Literature DB >> 28386727

What's new in pharmacokinetics of antimicrobials in AKI and RRT?

Jason A Roberts1,2,3,4, Jean-Yves Lefrant5,6, Jeffrey Lipman7,8.   

Abstract

Keywords:  Antibiotic; Antibiotic resistance; Dialysis; Dosing; Pharmacodynamics

Mesh：

Substances：

Year:  2017        PMID： 28386727     DOI： 10.1007/s00134-017-4789-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.

Authors:  Claire Roger; Steven C Wallis; Laurent Muller; Gilbert Saissi; Jeffrey Lipman; Jean-Yves Lefrant; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.

Authors:  Ilias Karaiskos; Lena E Friberg; Lambrini Galani; Konstantinos Ioannidis; Emmanouela Katsouda; Zoe Athanassa; Harris Paskalis; Helen Giamarellou
Journal:  Int J Antimicrob Agents       Date:  2016-07-18       Impact factor: 5.283

3.  Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.

Authors:  Janattul-Ain Jamal; Mohd-Basri Mat-Nor; Fariz-Safhan Mohamad-Nor; Andrew A Udy; Steven C Wallis; Jeffrey Lipman; Jason A Roberts
Journal:  Int J Antimicrob Agents       Date:  2014-10-18       Impact factor: 5.283

4.  Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements.

Authors:  Marta Ulldemolins; Dolors Soy; Mireia Llaurado-Serra; Sergi Vaquer; Pedro Castro; Alejandro H Rodríguez; Caridad Pontes; Gonzalo Calvo; Antoni Torres; Ignacio Martín-Loeches
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.

Authors:  E Muhl; T Martens; H Iven; P Rob; H P Bruch
Journal:  Eur J Clin Pharmacol       Date:  2000-12       Impact factor: 2.953

6.  Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.

Authors:  Janattul-Ain Jamal; Darren M Roberts; Andrew A Udy; Mohd-Basri Mat-Nor; Fariz-Safhan Mohamad-Nor; Steven C Wallis; Jeffrey Lipman; Jason A Roberts
Journal:  Int J Antimicrob Agents       Date:  2015-03-28       Impact factor: 5.283

7.  Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.

Authors:  Matthew S Shotwell; Ross Nesbitt; Phillip N Madonia; Edward R Gould; Michael J Connor; Charbel Salem; Olufemi A Aduroja; Milen Amde; Joseph J Groszek; Peilin Wei; Maria E Taylor; Ashita J Tolwani; William H Fissell
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

8.  Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?

Authors:  Janattul-Ain Jamal; Andrew A Udy; Steven C Wallis; Dwarakanathan Ranganathan; Brett C McWhinney; Jacobus P J Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Int J Artif Organs       Date:  2015-08-04       Impact factor: 1.595

9.  A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study.

Authors:  Alexandre Brasseur; Maya Hites; Sandrine Roisin; Frédéric Cotton; Jean-Louis Vincent; Daniel De Backer; Frédérique Jacobs; Fabio Silvio Taccone
Journal:  J Antimicrob Chemother       Date:  2016-01-31       Impact factor: 5.790

10.  A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.

Authors:  Darren M Roberts; Xin Liu; Jason A Roberts; Priya Nair; Louise Cole; Michael S Roberts; Jeffrey Lipman; Rinaldo Bellomo
Journal:  Crit Care       Date:  2015-03-13       Impact factor: 9.097
View more
  3 in total

Review 1.  [Adequate anti-infective treatment : Importance of individual dosing and application].

Authors:  A Brinkmann; A C Röhr; A Köberer; T Fuchs; W A Krüger; C König; D Richter; M A Weigand; O R Frey
Journal:  Anaesthesist       Date:  2018-06       Impact factor: 1.041

2.  Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.

Authors:  Jan J De Waele; Murat Akova; Massimo Antonelli; Rafael Canton; Jean Carlet; Daniel De Backer; George Dimopoulos; José Garnacho-Montero; Jozef Kesecioglu; Jeffrey Lipman; Mervyn Mer; José-Artur Paiva; Mario Poljak; Jason A Roberts; Jesus Rodriguez Bano; Jean-François Timsit; Jean-Ralph Zahar; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2017-12-29       Impact factor: 17.440

Review 3.  Update on ventilator-associated pneumonia.

Authors:  Jean-Francois Timsit; Wafa Esaied; Mathilde Neuville; Lila Bouadma; Bruno Mourvllier
Journal:  F1000Res       Date:  2017-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.